Quanterix Corp Files 8-K/A Amendment

Ticker: QTRX · Form: 8-K/A · Filed: Sep 23, 2025 · CIK: 1503274

Quanterix Corp 8-K/A Filing Summary
FieldDetail
CompanyQuanterix Corp (QTRX)
Form Type8-K/A
Filed DateSep 23, 2025
Risk Levellow
Pages2
Reading Time3 min
Key Dollar Amounts$0.001
Sentimentneutral

Sentiment: neutral

Topics: amendment, financial-statements, exhibits

TL;DR

Quanterix filed an amendment to its 8-K, updating financial statements and exhibits from July 8, 2025.

AI Summary

Quanterix Corp filed an 8-K/A on September 23, 2025, to amend a previous filing. The amendment pertains to financial statements and exhibits, with the earliest event reported on July 8, 2025. The company is incorporated in Delaware and headquartered in Billerica, MA.

Why It Matters

This filing indicates an amendment to Quanterix's financial reporting, suggesting potential adjustments or clarifications to previously disclosed information.

Risk Assessment

Risk Level: low — This is a routine amendment to a previous filing, not indicating new material events or financial distress.

Key Players & Entities

  • Quanterix Corp (company) — Registrant
  • Delaware (jurisdiction) — State of incorporation
  • Billerica, MA (location) — Principal executive offices
  • July 8, 2025 (date) — Date of earliest event reported
  • September 23, 2025 (date) — Filing date

FAQ

What is the purpose of this 8-K/A filing?

This 8-K/A filing is an amendment to a previous report, specifically concerning financial statements and exhibits.

When was the earliest event reported in this filing?

The earliest event reported in this filing was on July 8, 2025.

What is Quanterix Corporation's state of incorporation?

Quanterix Corporation is incorporated in Delaware.

Where are Quanterix Corporation's principal executive offices located?

Quanterix Corporation's principal executive offices are located at 900 Middlesex Turnpike, Billerica, MA 01821.

What is the filing date of this 8-K/A?

This 8-K/A was filed as of September 23, 2025.

Filing Stats: 644 words · 3 min read · ~2 pages · Grade level 11.6 · Accepted 2025-09-23 16:06:24

Key Financial Figures

  • $0.001 — e on which registered: Common Stock, $0.001 par value per share QTRX The Nasdaq Glo

Filing Documents

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits. (a) Financial Statements of Business Acquired. The historical financial statements of Akoya were previously reported in Post Effective Amendment No. 2 to the Registration Statement on Form S-4 filed by Quanterix on June 4, 2025 (File No. 333-284932) and are omitted in reliance on General Instruction B.3 to Form 8-K. (b) Unaudited Pro Forma Financial Information The unaudited pro forma condensed combined financial statements for the year ended December 31, 2024 and as of and for the six months ended June 30, 2025 giving effect to the acquisition of Akoya are filed as Exhibit 99.1 to this Amendment No. 1 to the Current Report on Form 8-K and incorporated in this Item 9.01 by reference. (d) Exhibits Exhibit No. Description 99.1 Unaudited p ro f orma condensed combined f inancial s tatements of Quanterix Corporation and Akoya Biosciences, Inc. for the year ended December 31, 2024 and as of and for the six months ended June 30, 2025. 104 Cover Page Interactive Data File (embedded within the inline XBRL document)

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this Current Report to be signed on its behalf by the undersigned hereunto duly authorized. Date: September 23, 2025 QUANTERIX CORPORATION By: /s/ Vandana Sriram Name: Vandana Sriram Title: Chief Financial Officer

View Full Filing

View this 8-K/A filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.